FDA Adverse Event Malfunction Summary report: N

COULTER LH 780 HEMATOLOGY ANALYZER

MDR report key: 2171271 · Received July 1, 2011

Report

Report Number
1061932-2011-00799
Event Type
Malfunction
Date Received
July 1, 2011
Date of Event
March 27, 2008
Report Date
April 3, 2008
Manufacturer
BECKMAN COULTER, INC.
Product Code
GKZ
PMA / PMN Number
K061616
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

SERVICE WAS NOT DISPATCHED FOR THIS EVENT. PRODUCT LABELING WAS EVALUATED. AS PER PRODUCT LABELING, THE COULTER LH 780 HEMATOLOGY ANALYZER IS INTENDED FOR ANALYSIS OF WHOLE BLOOD AND CEREBROSPINAL, SEROUS, AND SYNOVIAL FLUIDS AND NOT PLATELET CONCENTRATE. INSTRUMENT GENERATED MESSAGES ALERTS THE OPERATOR TO FURTHER REVIEW THE SAMPLE. ROOT CAUSE IS UNK, BUT MAY BE ATTRIBUTED TO THE TYPE OF SAMPLE USED. ADDITIONALLY, INSTRUMENT GENERATED MESSAGES ALERTS THE OPERATOR TO FURTHER REVIEW THE SAMPLE. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A RETROSPECTIVE REVIEW CONDUCTED BETWEEN (B)(4) 2008 AND (B)(4) 2010 OF COMPLAINTS FOR ADD'L REPORTABLE EVENTS. THIS MDR REPRESENTS EVENT 1 OF 2 REPORTED BY THIS CUSTOMER. THIS MDR IS RELATED TO THE FOLLOWING MDRS THAT HAVE BEEN REPORTED: MDR 1061932-2011-00800.

Description of Event or Problem · 1

CUSTOMER REPORTED ERRONEOUS TEST RESULTS WERE OBTAINED FOR A PLATELET CONCENTRATE PRODUCT SAMPLE WHEN USING THE COULTER LH 780 HEMATOLOGY ANALYZER. ERRONEOUS TEST RESULTS WERE RELEASED FOR THE PLATELET CONCENTRATE PRODUCT SAMPLE. THE TEST RESULTS WERE QUESTIONED, PROMPTING THE LAB TO REVIEW THE TEST RESULTS. NO REPORTS OF DEATH OR SERIOUS INJURY, AND NO AFFECT TO PT TREATMENT AS A RESULT OF THIS EVENT. THIS EVENT REPRESENTS EVENT 1 OF 2 EVENTS REPORTED BY THIS CUSTOMER. THIS IS THE FIRST OF TWO PLATELET CONCENTRATE PRODUCTS TESTED ON TWO SEPARATE DAYS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COULTER LH 780 HEMATOLOGY ANALYZER GKZ BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 UNK